EUTM file information

018902896

DAGESIN


July 17, 2023

Trademark Summary

The trademark DAGESIN was filed by POLFARMEX S.A., a corporation established under the laws of the Republic of Poland (the "Applicant"). The application was published for oppositions on July 30, 2023, and received undefined oppositions.

Opposition Proceedings

There are undefined Oppositions claimed against trademark.

The first opposition filed on October 17, 2023 by LABORATÓRIOS BASI - INDÚSTRIA FARMACÊUTICA, S.A. on Likelihood of confusion. the opponent was represented by Pinto de Oliveira, Abel Dário and its proceedings were handled in English The second opposition filed on October 15, 2023 by KRKA, tovarna zdravil, d.d., Novo mesto on Likelihood of confusion. the opponent was represented by UEXKÜLL & STOLBERG PARTNERSCHAFT VON PATENT- UND RECHTSANWÄLTEN MBB and its proceedings were handled in English The third opposition filed on September 25, 2023 by WALMARK a.s. on Likelihood of confusion. the opponent was represented by HARMSEN UTESCHER and its proceedings were handled in English

The application was filed in Polish, and Polish was also language of all opposition proceedings (English was selected as the second language).

The Opposition with reference B 003205141 was refused according to Article 8(1)(b) EUTMR with decision issued on July 11, 2024 by the EUIPO.


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Medicines for human purposes
    2. Hypoglycemic drugs
    3. Antihypertensives
    4. Antiarrhythmic agents
    5. Anticoagulants
    6. Anti-diabetic preparations
    7. Cardiovascular preparations.